Neuroscience Institute Will Position Lancaster General Health/Penn Medicine as Area Leader in Neurological Care, Research

By Jennifer Webster
Thursday, April 20, 2017
Specialty: 

Lancaster General Health/Penn Medicine is bringing together a multidisciplinary roster of programs, jointly located at a single, convenient facility, to benefit patients throughout Central Pennsylvania. The Neuroscience Institute, scheduled to open this summer, will facilitate patient access to expert specialty care, provide space for new initiatives and participate in leading-edge clinical investigation.

“Previously, neurologic care in the area was fragmented,” says Timothy Martin, DO, PhD, Managing Physician at the neurology practice at LG Health and Chief of the Division of Neurology. “Now, we will be able to offer the full spectrum of care, from diagnosis and medical management to recovery, all in one location.”

Within the 22,000-square-foot Institute, an interdisciplinary team of physicians and therapists will practice side by side, creating synergies and fostering care coordination among clinicians with wide-ranging expertise. Uniting services also ensures patients can move easily from one appointment to another, streamlining workflow.

“Patients will benefit from Penn Medicine more broadly through telemedicine,” says Jan Bergen, President and CEO of LG Health. “Remote consultations will enhance diagnosis and treatment by leveraging the knowledge and experience of Penn Medicine’s world-renowned providers.”

Services provided at the Institute will include neurology, electrodiagnostics, neuropsychology, Alzheimer’s and memory care, physiatry, and outpatient rehabilitation by physical, occupational and speech therapists with advanced training in neurological care. Specialty programs will focus on dizziness and balance, spinal cord injuries, movement disorders such as Parkinson’s disease, stroke and brain injury recovery, and post-concussion syndrome.

Also slated to be housed at the Institute is a Headache Clinic, which, according to Dr. Martin, will address a regional gap in care for patients with chronic headaches.

Anticipated services at the Neuroscience Institute do not end there, however. Advanced in-hospital stroke care under the leadership of Murray Flaster, MD, PhD, Stroke Program Director, will be extended to the outpatient arena in collaboration with Penn Medicine.

“We want to provide a seamless transition of care by offering a robust outpatient program for stroke follow-up and evaluation,” Dr. Martin says. “Additionally, we plan to further expand the Alzheimer’s and Memory Care program, which is already one of the strongest and largest in Central Pennsylvania. We also will increase offerings for patients with Parkinson’s disease, multiple sclerosis, and peripheral nerve and muscle problems.”

Further, Penn Medicine will bring advanced treatment options to local patients through access to participation in clinical trials.

“For example, many of our patients from the memory care program — especially those with rare dementia subtypes — will benefit from Penn Medicine’s research in that area,” Dr. Martin says. “It’s a win-win situation; we will collaborate with and learn from them, and we will bring our patients their world-renowned expertise.”


To learn more, visit LGHealth.org.